Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 133 | 233 | 0 | 34 | 0 |
| Gross Profit | 133 | 233 | N/A | 34 | 0 |
| Operating Expenses | 7,003 | 5,844 | 0 | 3,669 | 0 |
| Operating Income | -6,870 | -5,611 | N/A | -3,635 | N/A |
| Other Income | 1 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -6,869 | -5,611 | 0 | -3,635 | 0 |
| Net Income Continuous | -6,869 | -5,611 | N/A | -3,635 | 0 |
| Net Income | $-6,869 | $-5,611 | $N/A | $-3,635 | $0 |
| EPS Basic Total Ops | -42.88 | -37.78 | N/A | -29.54 | N/A |
| EPS Basic Continuous Ops | -42.84 | -37.79 | N/A | -29.51 | N/A |
| EPS Diluted Total Ops | -42.88 | -37.78 | N/A | -29.54 | N/A |
| EPS Diluted Continuous Ops | -42.84 | -37.79 | N/A | -29.51 | N/A |
| EBITDA(a) | $-6,835 | $-5,577 | $N/A | $-3,601 | $N/A |